---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-012639"
form_type: "8-K"
ticker: null
cik: "0002008861"
company_name: "Endo LP"
filed_at: "2024-08-27T23:59:59+00:00"
generated_at: "2026-05-31T07:30:20.385891+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Endo CEO Blaise Coleman departs; Board member Scott Hirsch named Interim CEO

## Summary
- Blaise Coleman to step down as President & CEO and from the Board effective August 29, 2024; no disagreements cited.
- Scott Hirsch, Board member since April 2024, appointed Interim CEO effective August 29; search underway for permanent CEO.
- Hirsch receives $250k/month base salary ($400k/month if still interim after Dec 31, 2024); no severance or incentive plan eligibility.
- Committee changes: Hirsch leaves Compensation & Compliance; Paul Herendeen joins Compensation, Sophia Langlois chairs it and joins Compliance.
- Board retained Spencer Stuart to assist CEO search; company reiterates focus on relisting and portfolio execution.

## SEC filing metadata
- accession: 0000950103-24-012639
- form_type: 8-K
- cik: 0002008861
- company_name: Endo LP
- filed_at: 2024-08-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2008861/000095010324012639/0000950103-24-012639-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2008861/000095010324012639/dp217093_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-012639
- JSON: https://secwatch.observer/filing/0000950103-24-012639.json
- Plain text: https://secwatch.observer/filing/0000950103-24-012639.txt

## Key facts
- Executive change
  Blaise Coleman departed as President and Chief Executive Officer at Endo LP.
  - Action: no longer serve
  - Role: President and Chief Executive Officer
  source text: On August 25, 2024, the Board of Directors (the “Board”) of Endo, Inc. (the “Company”) determined that Blaise Coleman will no longer serve as the Company’s President and Chief Executive Officer, effective August 29, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2008861/000095010324012639/0000950103-24-012639-index.htm
- Executive change
  Scott Hirsch was appointed as Interim Chief Executive Officer at Endo LP.
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: The Board has appointed Scott Hirsch, currently a Board member, to serve as the Company’s Interim Chief Executive Officer (“Interim CEO”), effective August 29, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2008861/000095010324012639/0000950103-24-012639-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.